methionine has been researched along with Acanthosis Nigricans in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buckley, MF; Elakis, G; Gardener, G; Inglis, G; Roscioli, T; Susman, RD; Zankl, A | 1 |
| Bamshad, MJ; Bellus, GA; Curry, CJ; Dorst, J; Francomano, CA; Hurko, O; Jabs, EW; Lachman, RS; Lee, RR; Przylepa, KA; Rimoin, DL; Wilcox, WR | 1 |
2 other study(ies) available for methionine and Acanthosis Nigricans
| Article | Year |
|---|---|
Prenatal and postnatal presentation of severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) due to the FGFR3 Lys650Met mutation.
Topics: Acanthosis Nigricans; Achondroplasia; Amino Acid Substitution; Developmental Disabilities; Female; Fetus; Humans; Infant, Newborn; Lysine; Male; Methionine; Mutation, Missense; Pregnancy; Receptor, Fibroblast Growth Factor, Type 3; Ultrasonography, Prenatal | 2008 |
Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3.
Topics: Acanthosis Nigricans; Developmental Disabilities; Female; Humans; Infant, Newborn; Lysine; Male; Methionine; Osteochondrodysplasias; Phenotype; Point Mutation; Protein-Tyrosine Kinases; Radiography; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Fibroblast Growth Factor; Skull | 1999 |